SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Reports that Volkswagen is considering Xpeng software for many European models have raised concerns that Rivians software partnership could be sidelined, adding to pressure on shares near 52-week lows ahead of earnings. Traders are split between buying the decline and worrying about the partnership, profitability, and execution.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeings Q3 results and commentary on a slower 737 production ramp triggered a sharp selloff, as traders focused on the wider-than-expected core loss and uncertainty over the cash-flow turnaround. The community is split between concerns about continued execution delays and optimism that Boeings large backlog and improving cash generation support a longer-term recovery.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas sharp rebound is drawing attention after Barclays upgraded the stock, with traders also citing speculation about a potential SpaceX merger and optimism around robotaxis and FSD. Bulls see momentum continuing, while skeptics argue the rally is driven by hype despite weak earnings and a stretched valuation; the merger remains uncertain.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

ENPH is drawing attention amid a sustained selloff in solar stocks, with traders citing rising borrowing costs and yields, soft residential demand, and analyst concerns about the outlook as headwinds. Some see the shares as oversold and point to future growth from IQ SST and data-center products, while others expect further weakness; short-squeeze talk remains speculative.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhoods quarterly earnings are driving attention, with traders reacting to a sharp post-report selloff and debating whether the results or outlook disappointed despite expectations for growth. Some remain bullish on the companys broader platform and trading activity, while others point to crypto revenue and a history of shares falling after earnings as risks.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Reports of abrupt layoffs affecting roughly 550 workers in India, with additional cuts in the Philippines, have fueled a sharp selloff amid concern that a client project or major customers work is being reduced. Traders are divided between viewing the decline as an overreaction to a limited workforce cut and fearing a revenue hit, with many seeking clarification from management ahead of earnings.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Googles reported quantum-computing breakthrough in magic-state cultivation has revived interest across quantum stocks, with traders speculating that progress could benefit Infleqtions neutral-atom technology. The discussion also reflects a rebound after a steep selloff, though the connection to INFQ is indirect and some traders remain cautious about the stocks weakness.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs pending decision on Capricors deramiocel for Duchenne muscular dystrophy, with traders focused on the narrowed upper-limb indication and submitted HOPE-3 extension data. Bulls argue the efficacy evidence and potential regulatory flexibility support approval, while skeptics point to the earlier advisory-panel concerns and statistical uncertainties; the stocks weakness and reported short interest add to the debate over this binary catalyst.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

President Trumps plans for expanded oil, gas and mineral exploration in Greenland have renewed interest in CRMLs Tanbreez rare-earth project, with traders also speculating about a short squeeze. Others caution that new shares from the European Lithium merger could add dilution pressure.

Better Home & Finance Holding Co. engages in the provision of comprehensive homeownership services. It offers mortgage loans, real estate agent services, and title and homeowner's insurance services. The company was founded in 2014 and is headquartered in New York, NY.

Better Home & Finance Holding Co. - Ordinary Shares - Class A

Better Home & Finance Holding Co.

BETRs sharp rally is fueling a short-squeeze narrative, with traders pointing to the companys share-repurchase program, the stocks low float and high short interest, and ongoing turnaround updates. Others caution that a squeeze is unconfirmed and question whether the rally has enough volume or business progress to sustain it.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 1,065 Shares of Stock

Tectonic Therapeutic, Inc. (NASDAQ:TECX - Get Free Report) insider Marcella Ruddy sold 1,065 shares of Tectonic Therapeutic stock in a transaction dated Monday, May 4th. The stock was sold at an...

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages

Tectonic Therapeutic, Inc. (NASDAQ:TECX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight brokerages that are covering the company, Marketbeat.com...

Tectonic Therapeutic (NASDAQ:TECX) Rating Lowered to "Strong Sell" at Wall Street Zen

Wall Street Zen cut shares of Tectonic Therapeutic from a "sell" rating to a "strong sell" rating in a report on Saturday...

Aberdeen Group plc Acquires 785,648 Shares of Tectonic Therapeutic, Inc. $TECX

Aberdeen Group plc boosted its holdings in shares of Tectonic Therapeutic, Inc. (NASDAQ:TECX - Free Report) by 220.6% in the fourth quarter, according to the company in its most recent 13F filing...

Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 1,000 Shares of Stock

Tectonic Therapeutic, Inc. (NASDAQ:TECX - Get Free Report) insider Marcella Ruddy sold 1,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $31.05, for a total value of $31,050.00. Following the sale, the insider directly...

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Tectonic Therapeutic, Inc. (NASDAQ:TECX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven analysts that are covering the company, MarketBeat Ratings...

Tectonic Therapeutic (NASDAQ:TECX) Insider Marcella Ruddy Sells 1,000 Shares

Tectonic Therapeutic, Inc. (NASDAQ:TECX - Get Free Report) insider Marcella Ruddy sold 1,000 shares of Tectonic Therapeutic stock in a transaction on Wednesday, April 1st. The shares were sold at an...

Tectonic Therapeutic (NASDAQ:TECX) Shares Up 9.3%  - What's Next?

Tectonic Therapeutic (NASDAQ:TECX) Shares Up 9.3% - Here's What Happened...

First Light Asset Management LLC Makes New $3.18 Million Investment in Tectonic Therapeutic, Inc. $TECX

First Light Asset Management LLC acquired a new position in Tectonic Therapeutic, Inc. (NASDAQ:TECX - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities...

Braidwell LP Makes New $11.56 Million Investment in Tectonic Therapeutic, Inc. $TECX

Braidwell LP purchased a new position in Tectonic Therapeutic, Inc. (NASDAQ:TECX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the...

Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of therapeutic proteins and antibodies that modulate the activity of G protein-coupled receptors (GPCR). It develops a proprietary technology platform called GEODe to enable the discovery and development of GPCR-targeted biologic medicines. The company was founded by Timothy A. Springer and Andrew Kruse in November 2015 and is headquartered in Watertown, MA.

Tectonic Therapeutic Inc.

Why Tectonic Therapeutic Stock Soared 30% After-Hours Today

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>TX45, Tectonic’s experimental Fc-relaxin fusion protein, showed strong improvements in heart and lung function with no serious safety issues in patients with heart failure-related pulmonary hypertension.</li><li>The results expand the drug’s potential reach to a broader patient population with no approved therapies, while the Phase 2 APEX trial continues toward results in 2026.</li><li>Retail investors reacted enthusiastically on Stocktwits, calling the data “unbelievable” and “outstanding.”&nbsp;</li></ul>Shares of Tectonic Therapeutic rose about 30% in after-hours trading on Wednesday after the company reported positive topline results from a Phase 1b Part B clinical trial of TX45, its experimental Fc-relaxin fusion protein, in patients with Group 2 pulmonary hypertension associated with heart failure with reduced ejection fraction.<h2 class="st-heading-2">TX45 Shows Improvements In Heart And Lung Function</h2>Tectonic said a single intravenous dose of TX45 was well tolerated, with no serious side effects or meaningful changes in blood pressure. The treatment showed clear benefits for heart and lung function by reducing pressure on the heart and lungs and improving blood flow. Key measures, such as pulmonary capillary wedge pressure, total pulmonary resistance, and mean pulmonary artery pressure, all decreased, while cardiac output increased.CEO Alise Reicin said the findings “open up the potential to expand into this additional patient population with significant unmet need and no approved therapies,” adding that the results mirrored those seen in an earlier TX45 study in heart failure with preserved ejection fraction.<h2 class="st-heading-2">Broader Development Plan</h2>The trial enrolled 14 patients and builds on earlier positive data from TX45’s Phase 1b Part A study in ejection fraction. The company is currently running the APEX Phase 2 trial to test TX45 over a 24-week treatment period in patients with ejection fraction, with topline results expected in 2026.Chief Medical Officer Marcella Ruddy said the drug showed “persistent effects at day 29” based on echocardiographic data and continued to demonstrate a favorable safety profile.<h2 class="st-heading-2">Stocktwits Users Cheer Tectonic’s TX45 Results</h2>On Stocktwits, retail sentiment for Tectonic Therapeutic was ‘extremely bullish’ amid ‘extremely high’ message volume.One user described the TX45 results as “unbelievable,” predicting the stock could reach $50.&nbsp;<stembedurl>https://stocktwits.com/paddypablo/message/634229088</stembedurl>Another user said the data looked “outstanding,” adding to their position below $22 and expecting the shares to climb further.<stembedurl>https://stocktwits.com/Gurujoe/message/634224719</stembedurl><a href="https://stocktwits.com/symbol/TECX">Tectonic’s stock</a> has declined 60% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tectonic’s stock (TECX) has declined 60% so far in 2025. (Photo credit: Getty Images)

TX45, Tectonic’s experimental Fc-relaxin fusion protein, showed strong improvements in heart and lung function with no serious safety issues in patients with heart failure-related pulmonary hypertension.

50bps hike

25bps hike

No change

Rate cut

The Federal Reserve announces its rate decision Wednesday, October 28 at 2:00 PM ET, followed by Chair Kevin Warsh’s press conference at 2:30 PM, after raising rates by a quarter point to 3.75%-4.00% in September, its first hike since 2023. What do you think the Fed decides on Wednesday? Vote and explain your reasoning in the comments.

Current Price	$20.35
Prev Close	$19.95
Open	$20.27
Dividend Yield	0.00%
50-Day Moving Average	$27.26
Beta	1.39
Avg. Volume	229,174.52
PE Ratio	-4.37

52-Week High	$39.53
52-Week Low	$15.52
Market Capitalization	$390.01M
EPS (Annual)	-$4.05
Price to Book	1.71
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

TECX Fundamentals